Updated January 25 at 4:55pm
Life Sciences
13 results total, viewing 1 - 10
Voyager Therapeutics, a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system, has entered into a strategic collaboration with MassBiologics of the University of Massachusetts Medical School. more
Moderna Therapeutics has announced another record venture capital investment: $450 million. more
EpiVax Inc. and Novozymes Biopharma entered into a license agreement for the development of treatments for autoimmune diseases, the companies announced on Monday. more
A Cherrystone Angel Group portfolio company, Windgap Medical Inc., was awarded nearly $1 million through a Massachusetts Life Sciences Center accelerator loan program. more
(Updated, 5:14 p.m.) A Cherrystone Angel Group portfolio business has entered into an acquisition agreement of $140 million with a European buyer specializing in bio-analytical testing and genomic services. more
IlluminOss Medical has received conditional approval from the federal Food and Drug Administration to conduct a clinical trial for treatments of impending and pathologic fractures in the humerus due to metastatic carcinoma. more
Mnemosyne Pharmaceuticals Inc. appointment of Vanessa King as president and CEO. more
The Bill and Melinda Gates Foundation has awarded a $100,000 grant to the GAIA Vaccine Foundation to raise awareness about the prevention of cervical cancer in West Africa. more
Venture capital firm SV Life Sciences has acquired a majority interest in Ximedica from co-founders Stephen Lane and Aidan Petrie. more
A Japanese biopharmaceutical company has contracted to begin using a protein-screening interface developed by Providence-based EpiVax Inc. more
1 | 2 Next »